Abstract:Tumor microenvironment (TME), is characterized by a complex and heterogenous composition involving a substantial population of immune cells. Myeloid cells comprising over half of the solid tumor mass, are undoubtedly one of the most prominent cell populations associated with tumors. Studies have unambiguously established that myeloid cells play a key role in tumor development, including immune suppression, pro-inflammation, promote tumor metastasis and angiogenesis, for example, tumor-associated macrophages promote tumor progression in a variety of common tumors, including lung cancer, through direct or indirect interactions with the TME. However, due to previous technological constraints, research on myeloid cells often tended to be conducted as studies with low throughput and limited resolution. For example, the conventional categorization of macrophages into M1-like and M2-like subsets based solely on their anti-tumor and pro-tumor roles has disregarded their continuum of states, resulting in an inadequate analysis of the high heterogeneity characterizing myeloid cells. The widespread adoption of single-cell RNA sequencing (scRNA-seq) in tumor immunology has propelled researchers into a new realm of understanding, leading to the establishment of novel subsets and targets. In this review, the origin of myeloid cells in high-incidence cancers, the functions of myeloid cell subsets examined through traditional and single-cell perspectives, as well as specific targeting strategies, are comprehensively outlined. As a result of this endeavor, we will gain a better understanding of myeloid cell heterogeneity, as well as contribute to the development of new therapeutic approaches.

Heterogeneous Molecules of Vascular Endothelial Cells in Tumors

Aberrant tumor vasculature. Facts and pitfalls

Heterogeneity of tumor lymphangiogenesis: progress and prospects.

A narrative review of tumor heterogeneity and challenges to tumor drug therapy

Progress in Research on the Relationships among Tumor Blood Supply Patterns

Heterogeneity of the tumor immune microenvironment and its clinical relevance

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

Heterogeneous Myeloid Cells in Tumors

Review on Biofabrication and Applications of Heterogeneous Tumor Models

Heterogeneity in Primary Tumors and Corresponding Metastases: Could It Provide Us with Any Hints to Personalize Cancer Therapy?

Anti-angiogenic Therapy for Tumor: Tumor Angiogenesis, Vasculogenic Mimicry and Vascular Normalization

Advances in tumor vascular growth inhibition

Metabolic Heterogeneity in Cancer: an Overview and Therapeutic Implications

Heterogeneity of myeloid cells in common cancers: Single cell insights and targeting strategies

Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments

Quantifying Tumor Vascular Heterogeneity with Dynamic Contrast-Enhanced Magnetic Resonance Imaging: A Review

The Origins Of Vacularization In Tumors

Emerging role of interactions between tumor angiogenesis and cancer stem cells

Molecular heterogeneity of hepatocellular carcinoma and its precise treatment in clinical practice

Progress on angiogenic and antiangiogenic agents in the tumor microenvironment

Vascular Endothelial Progenitor Cells and Their Contributions to Tumor